Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mesenchymal Stromal Cells for Traumatic Brain Injury — Stella

Home/Traumatic Brain Injury With Loss of Consciousness/Mesenchymal Stromal Cells for Traumatic Brain Injury

View on ClinicalTrials.gov

Recruiting

Back to Traumatic Brain Injury With Loss of Consciousness trials

Mesenchymal Stromal Cells for Traumatic Brain Injury

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Italy

Fondazione IRCCS San Gerardo dei Tintori, Monza, MB

ASST Ospedale Papa Giovanni XXIII Bergamo, Bergamo

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico of Milano, Milan

Key details

Phase

Safety & dosing

Sponsor

Fondazione IRCCS San Gerardo dei Tintori

Collaborators

Istituto Di Ricerche Farmacologiche Mario Negri, A.O. Ospedale Papa Giovanni XXIII

Enrollment target

~78 participants

Started

September 2023

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated December 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.